Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Ruixia Liang"'
Autor:
Ruixia Liang, Jiankang Li, Yue Zhao, Haoran Qi, Shengjuan Bao, Fen Wang, Hongfei Duan, Hairong Huang
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
ObjectivesMatrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a potent tool for detecting drug resistance in tuberculosis (TB); however, concerns about its reliability have been raised. In this s
Externí odkaz:
https://doaj.org/article/8e460c945fed4873822557aa5f0f3829
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Miliary tuberculosis (TB) is one of the severest manifestations of TB that can be lethal when concomitant with the central nervous system (CNS) involvement. Bacteriological, biochemical and radiological methods for find CNS comorb
Externí odkaz:
https://doaj.org/article/0a6ca819278843eebcb5e64347d55611
Autor:
Andrej Trauner, Qingyun Liu, Laura E. Via, Xin Liu, Xianglin Ruan, Lili Liang, Huimin Shi, Ying Chen, Ziling Wang, Ruixia Liang, Wei Zhang, Wang Wei, Jingcai Gao, Gang Sun, Daniela Brites, Kathleen England, Guolong Zhang, Sebastien Gagneux, Clifton E. Barry, Qian Gao
Publikováno v:
Genome Biology, Vol 18, Iss 1, Pp 1-17 (2017)
Abstract Background Combination therapy is one of the most effective tools for limiting the emergence of drug resistance in pathogens. Despite the widespread adoption of combination therapy across diseases, drug resistance rates continue to rise, lea
Externí odkaz:
https://doaj.org/article/ebb36b859559438eaa6e2ee80399bb27
Publikováno v:
Future Microbiology; June 2024, Vol. 19 Issue: 9 p783-793, 11p
Autor:
Ruixia Liang, Yingxiang Gao, Fangfang Yang, Yingrui Han, Zuopeng Wang, Richard Liu, Charles Ying Wang, Jason Bin Zhang, Xiangyang Chen, Davy Xuesong Ouyang
Publikováno v:
Cancer Research. 83:4012-4012
Background: SHP2 is a non-receptor protein tyrosine phosphatase which functions as a convergent signaling node downstream of multiple receptor tyrosine kinases (RTKs), and upstream of RAS to promote oncogenic signaling and tumor growth. SHP2 also med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::720d57af3fbffc52ef307eda8c6dd643
https://doi.org/10.1158/1538-7445.am2023-4012
https://doi.org/10.1158/1538-7445.am2023-4012
Autor:
Hongjuan Zhang, Ruixia Liang, Haipeng Xu, Xiaorong Li, Renbin Zhao, Jason Bin Zhang, Davy Xuesong Ouyang
Publikováno v:
Cancer Research. 83:4013-4013
Background: R-CHOP has been widely recognized as effective first-line treatment for DLBCL. However, 30-50% of the patients are either refractory or eventually develop relapsed diseases (r/r DLBCL). The CD19-targeted cytolytic antibody tafasitamab, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebb50dd66ee1b243ac2bd1732f30588d
https://doi.org/10.1158/1538-7445.am2023-4013
https://doi.org/10.1158/1538-7445.am2023-4013
Autor:
Ruixia Liang, Yucheng Pang, Yingrui Han, Haipeng Xu, Zuopeng Wang, Richard Liu, Charles Ying Wang, Jason Bin Zhang, Xiangyang Chen, Davy Xuesong Ouyang
Publikováno v:
Cancer Research. 83:3427-3427
Background: Cereblon (CRBN)-targeting immunomodulatory drugs (IMiDs), i.e., thalidomide and lenalidomide, play pivotal roles in treating multiple myeloma (MM) patients. This class of drugs induce rapid ubiquitination and degradation of two lymphoid t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eeb1fa34e79c222a7d8883860320bbe4
https://doi.org/10.1158/1538-7445.am2023-3427
https://doi.org/10.1158/1538-7445.am2023-3427
Publikováno v:
BMC Infectious Diseases. 22
Background Miliary tuberculosis (TB) is one of the severest manifestations of TB that can be lethal when concomitant with the central nervous system (CNS) involvement. Bacteriological, biochemical and radiological methods for find CNS comorbidity in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cb4336614c0c5d0c5728d24f73b55a
https://doi.org/10.1186/s12879-022-07390-7
https://doi.org/10.1186/s12879-022-07390-7
Autor:
Ruixia Liang, Chao Zhou, Yingrui Han, Prince Lu, Charles Ying Wang, Zuopeng Wang, Richard Liu, Norman Kong, Jason Bing Zhang, Jasmine Jisong Cui, Davy Xuesong Ouyang
Publikováno v:
Cancer Research. 82:6187-6187
Background: Somatic oncogenic fusions of NTRK with other genes, such as ETV6, LMNA, TPM3, PAN3, etc. occur in a wide range of adult and pediatric tumors. Clinical application of 1st generation TRK inhibitors, i.e., larotrectinib and entrectinib, for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2cf1bdd6014620db82df6430a6fcc674
https://doi.org/10.1158/1538-7445.am2022-6187
https://doi.org/10.1158/1538-7445.am2022-6187
Autor:
Jianjun Liu, Guihui Wu, Shiming Chen, Xin Shen, Ted Cohen, Chongguang Yang, Liqiong Bai, Qingshan Cai, Shouyong Tan, Pei-Lan Zong, Shucai Wu, Jia'An Xia, Peng Sun, Xiaolin Wang, Xiaohong Kan, Ruixia Liang, Zhong Zeng, Qichao Pan, Zhengan Yuan, Wei Sha, Kaixing Ai, Cui Cai
It is crucial to maintain continuity of essential services for people affected by tuberculosis (TB). Efforts to deliver these essential services in many global settings have been complicated by the emergence and global spread of SARS-CoV-2 and the pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b892f5e820bba8597f0e45c7cd64d95b
https://doi.org/10.1101/2020.07.16.20150292
https://doi.org/10.1101/2020.07.16.20150292
